---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-21-030193"
form_type: "8-K"
ticker: "OTLC"
cik: "0000908259"
company_name: "Oncotelic Therapeutics, Inc."
filed_at: "2021-12-01T23:59:59+00:00"
generated_at: "2026-06-28T04:42:59.736026+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Oncotelic issues $0.5M in convertible notes at $0.07/share to repay existing debt

## Summary
- Issued two convertible notes: $0.25M to Talos Victory Fund and $0.25M to Mast Hill Fund.
- Notes carry 12% annual interest, mature in one year, convertible at $0.07 per share.
- Proceeds used to fully repay May 2021 Geneva Note ($203,750) and June 2021 Geneva Note ($103,750).
- Financing round aims for up to $1.0M; first two tranches total $0.5M.
- JH Darbie & Co. entitled to 10% cash finder's fee and 10% warrant coverage.

## SEC filing metadata
- accession: 0001493152-21-030193
- form_type: 8-K
- ticker: OTLC
- cik: 0000908259
- company_name: Oncotelic Therapeutics, Inc.
- filed_at: 2021-12-01T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/908259/000149315221030193/0001493152-21-030193-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/908259/000149315221030193/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-21-030193
- JSON: https://secwatch.observer/filing/0001493152-21-030193.json
- Plain text: https://secwatch.observer/filing/0001493152-21-030193.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.